Ohm, Thanks (as usual) for all your expertise and
Post# of 155189
Reading between the lines, I get the sense you are not 100% convinced we have completely nailed down the MOA for LL and how it works with checkpoint inhibitors. Apologies if I have misread your posts, but -
Question: Are you satisfied with our current understanding of our MOA re: turning "cold" tumors "hot?" Or do you think there's 10% - 20% that we still have to learn?

